Analyst firms · Evercore ISI · PG

Evercore ISI PG price target and rating history

Procter & Gamble Company (PG) · Consumer Discretionary

Evercore ISI rates Procter & Gamble Company (PG) Outperform with a $166 price target, as of its latest action on Oct 6, 2026. It has published 3 rating actions on PG since April 2023, including 1 upgrade and 1 downgrade. Across 7 firms with a PG price target in the last 12 months, the median target is $156. Evercore ISI's $166 is 6% above that.

Current rating
Outperform
Price target
$166
Median target, all firms
$156
Actions on PG
3

Evercore ISI price target on PG

$170$168$166202420252026
Evercore ISI price target on PG, each point a stated target, April 2023 to October 2026.

Every Evercore ISI rating on PG

How other firms rate PG

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Evercore ISIOutperform$166Oct 6, 2026
Argus ResearchHoldAug 7, 2026
BernsteinMkt Perform$156Jun 12, 2026
Erste GroupHoldMar 24, 2026
TD CowenHold$156Jan 27, 2026
Piper SandlerNeutral$150Jan 7, 2026
JefferiesBuy$179Dec 17, 2025
BarclaysEqual Weight$151Dec 8, 2025
Deutsche BankBuy$171Dec 8, 2025

Questions about Evercore ISI and PG

What is Evercore ISI's price target for PG?
Evercore ISI's latest stated price target for Procter & Gamble Company (PG) is $166, from its action on Oct 6, 2026.
What is Evercore ISI's rating on PG?
Evercore ISI rates PG Outperform, a bullish rating, as of Oct 6, 2026.
When did Evercore ISI last change its view on PG?
On Oct 6, 2026, Evercore ISI upgrades to Outperform from In-line, price target $166.
How does Evercore ISI's PG target compare with other analysts?
Across 7 firms with a PG price target in the last 12 months, the median target is $156. Evercore ISI's $166 is 6% above that.

More PG rating histories

All Evercore ISI ratingsPG news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.